Skip to main content
WLYBJohn Wiley & Sons, Inc.Hold6.1·$52.24-1.79%
WLYB · Concentration risk · 10-K extracted

John Wiley & Sons (WLYB) concentration risks

Updated

The most significant concentration John Wiley & Sons discloses is Research segment at 64%, classified HIGH by disclosed size. Below: the full set from the latest 10-K — verbatim quotes, filing references, and a synthesis of what these exposures mean together.

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Source: John Wiley & Sons’s SEC Form 10-K filed view the filing on SEC EDGAR ↗

At a glance

Disclosed-size breakdown · 1 disclosed concentration

HIGH1
MEDIUM0
LOW0
Disclosed concentrations

Each card carries a disclosed-size chip (HIGH / MEDIUM / LOW — how large the exposure is as a share of revenue, not how dangerous it is) and a nature tag: Built-in(the company’s own model, geography, or products) or Outside party (an external customer, supplier, or distributor it relies on).

HIGHBuilt-inProduct / Revenue mix
64%

Research segment

10-K Item 1: 'Research revenue accounted for approximately 64% of our consolidated revenue in the year ended April 30, 2025'
SEC 10-K · filed Jun 2025
TrendMatrix Research · concentration synthesis

What these concentrations mean together

updated 2026-08-23

Wiley's concentration profile, as disclosed, comes down to a single dominant segment: Research generated approximately 64% of consolidated revenue for the year ended April 30, 2025, easily the largest contributor to the top line. That share is described as a high-share exposure, and its character is structural — a function of how the company's business is organized rather than dependence on any one customer, supplier, or geography. No other concentration is disclosed among these source claims, so Research's dominance is effectively the whole story for evaluating how exposed Wiley's results are to a single part of the business. A structural concentration of this kind tends to move with the segment's underlying industry dynamics rather than with a single counterparty's decisions, which is a different — generally steadier — kind of risk than a customer or supplier dependency. Even so, with roughly two-thirds of revenue running through one segment, shareholders should expect consolidated results to track Research's trajectory closely, and any structural shift affecting that segment — pricing, access models, or research funding cycles — would have an outsized effect on Wiley as a whole rather than being absorbed by a diversified mix of businesses.

For the engine’s reasoning on WLYB’s current verdict — including which dimensions drove the score — see the per-dimension breakdown.

Industry peers · Publishing

Peer concentration profile

SymbolNameHIGHMEDIUMLOWTotal
TDAYUSA TODAY Co., Inc.1102
WLYJohn Wiley & Sons, Inc.1001
WLYBJohn Wiley & Sons, Inc.1001
NYTNew York Times Company (The)0101
SCHLScholastic Corporation0000

Concentration counts reflect items disclosed in each peer’s most recent 10-K; disclosed-size classification uses TrendMatrix’s internal 10-K extraction taxonomy.

Concentration disclosures are extracted verbatim from SEC 10-K filings; the disclosed-size classification and the synthesis above are engine-derived. Size reflects how large each exposure is against fixed share thresholds (HIGH >50%, MEDIUM 25–50%, LOW <25% or an explicit diversification statement), not a judgment of how dangerous it is, and is not a buy/sell rating, a price target, or a view on the stock. Not a complete list of risk factors — see the full filing.

Home Stocks WLYB Concentration risk